Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene. | Genes (Basel) | 2023 | 36833203 | PubTator, text mining | PubMed |
| Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics. | Diagnostics (Basel) | 2023 | 36832201 | PubTator, text mining | PubMed |
| Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations. | Cancers (Basel) | 2023 | 36831665 | PubTator, text mining | PubMed |
| Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer. | Cancers (Basel) | 2023 | 36831640 | PubTator, text mining | PubMed |
| Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy. | Cancers (Basel) | 2023 | 36831579 | PubTator, text mining | PubMed |
| The impact of coding germline variants on contralateral breast cancer risk and survival. | Am J Hum Genet | 2023 | 36827971 | PubTator, text mining | PubMed |
| Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN). | Curr Oncol Rep | 2023 | 36826704 | PubTator, text mining | PubMed |
| Network and pathway-based analysis of genes associated with esophageal squamous cell carcinoma. | Ann Transl Med | 2023 | 36819552 | PubTator, text mining | PubMed |
| FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study. | BMC Cancer | 2023 | 36809997 | PubTator, text mining | PubMed |
| Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma. | Transl Oncol | 2023 | 36805919 | PubTator, text mining | PubMed |
| Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes. | Clin Cancer Res | 2023 | 36805632 | PubTator, text mining | PubMed |
| Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. | Clin Cancer Res | 2023 | 36795432 | PubTator, text mining | PubMed |
| DNA repair deficiency as circulating biomarker in prostate cancer. | Front Oncol | 2023 | 36793600 | PubTator, text mining | PubMed |
| HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism. | J Transl Med | 2023 | 36793108 | PubTator, text mining | PubMed |
| Association of Reported Candidate Monogenic Genes With Lung Cancer Risk. | Clin Lung Cancer | 2023 | 36781323 | PubTator, text mining | PubMed |
| Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. | EMBO Mol Med | 2023 | 36779660 | PubTator, text mining | PubMed |
| Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. | Cancers (Basel) | 2023 | 36765927 | PubTator, text mining | PubMed |
| Candidate Genes and Pathways in Cervical Cancer: A Systematic Review and Integrated Bioinformatic Analysis. | Cancers (Basel) | 2023 | 36765810 | PubTator, text mining | PubMed |
| Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer. | Cancers (Basel) | 2023 | 36765776 | PubTator, text mining | PubMed |
| Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. | Cancers (Basel) | 2023 | 36765737 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=33